Dr. Lal PathLabs Ltd has fixed Friday, December 19, 2025, as the record date for its 1:1 bonus share issue. Under this bonus issue, eligible shareholders will receive one additional equity share for every share they currently hold.
Dr. Lal PathLabs Ltd said in an exchange filing, “The members of the company approved issuing bonus equity shares, in the proportion of 1:1 i.e., One (1) new fully paid-up equity share of face value of INR 10/- (Rupee Ten Only) each for every One (1) existing fully paid-up equity share of face value of INR 10/- (Rupee Ten Only) each to the eligible Members of the Company.”
In this regard, we wish to inform you that the Board of Directors today i.e. December 12, 2025, through Circular Resolution fixed “Friday, December 19, 2025” as the Record Date for the purpose of determining the eligibility of the Members of the Company for issuing bonus equity shares
Since December 19 has been set as the record date, December 18, 2025, was the last day for investors to purchase Dr. Lal PathLabs shares to qualify for the bonus issue. Shares bought on or after the record date will not be eligible for the bonus due to the T+1 settlement cycle. Investors must ensure that the shares are held in a valid demat account as of the record date to receive the bonus shares.
Also Read: Canara Robeco AMC Dividend Record Date is on Monday (December 22)
Dr. Lal PathLabs is a leading diagnostics and healthcare services provider in India, offering a wide range of tests for disease diagnosis, prevention, monitoring, and treatment through its extensive nationwide network. As of March 31, 2025, the company operated 298 clinical laboratories, including a National Reference Laboratory in Delhi and Regional Reference Laboratories in Kolkata, Bengaluru, and Mumbai. It also had a vast network of 6,607 Patient Service Centers and 12,365 Pick-up Points across India. Its clientele includes individual patients, hospitals, healthcare institutions, and corporate customers.
The company reported a strong financial performance, recording revenue growth of 10.7% in Q2FY26 and 11.0% in H1FY26. EBITDA increased by 10.8%, with margins at 30.7%, while PAT grew by 16.4%, achieving a margin of 20.8%. During the quarter, the company also declared an interim dividend of ₹7 per share and approved a 1:1 bonus issue, entitling shareholders to one bonus share for every share held as of the record date.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Dec 19, 2025, 8:51 AM IST
Sachin Gupta
Sachin Gupta is a Content Writer with 6+ years of experience in the stock market, including global markets like the US, Canada, and Australia. At Angel One, Sachin specialises in creating financial content that simplifies complex market trends. Sachin holds a Master's in Commerce, specialising in Economics.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
